2.0899 -0.00 (-0.00%)
After hours: 4:40PM EDT
Price Crosses Moving Average
|Bid||2.0800 x 1100|
|Ask||2.0900 x 3200|
|Day's Range||2.0600 - 2.2500|
|52 Week Range||0.8100 - 49.0000|
|Beta (5Y Monthly)||2.55|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 28, 2007|
|1y Target Est||N/A|
WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction.
If you're interested in NeuroMetrix, Inc. (NASDAQ:NURO), then you might want to consider its beta (a measure of share...
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we...
Once considered one of the state’s fastest-growing public companies, a Woburn medical device company has made a series of substantial cuts over the last year in the hopes of bringing the company out of the red.
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead ...
Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.